珍石烧伤膏对wistar大鼠深Ⅱ°烧伤创面愈合影响的研究

目的:通过动物实验观察珍石烧伤膏促进创面愈合情况,探究珍石烧伤膏治疗烧伤的作用机制及为指导临床治疗提供实验依据。方法:将78只wistar大鼠随机分为模型组(72只)及正常对照组(6只),模型组背部行深Ⅱ°烧伤后分3组:A组为同体对照,右侧创面涂珍石烧伤膏,左侧对照创面直接用凡士林油纱覆盖包扎。B组背部创面全部涂珍石烧伤膏。C组凡士林油纱覆盖。观察每组创面愈合程度、创面组织病理学变化、胶原的变化和羟脯氨酸含量。结果:珍石组大鼠不同时间点的创面愈合率均高于对照组(P<0.05),愈合时间明显缩短(P<0.05),愈合创面上皮化程度好于对照组,胶原分布规律,羟脯氨酸含量明显高于对照组。结论:珍石烧伤膏通过促进上皮细胞生长,刺激羟脯氨酸表达,调节胶原合成,减少瘢痕形成等机制促进伤口愈合。     

硝酸银软膏对Ⅱ度烧伤创面治疗作用的多中心临床研究

目的观察硝酸银(AgNO3)软膏对浅Ⅱ、深Ⅱ度烧伤创面的治疗效果,并评价其药物不良反应。方法选择80例浅Ⅱ度和40例深Ⅱ度烧伤患者,进行多中心、随机、阳性药物平行对照和同体试验研究(共4个中心,每个中心30例)。将患者创面按用药不同分为AgNO3组和磺胺嘧啶银(SD-Ag)组,观察各组创面完全愈合时间、指定时相点下创面愈合率、创面细菌培养情况、药物疗效和安全性、药物对创面的刺激性等。结果浅Ⅱ度创面:AgNO3组完全愈合时间为(9．5±2．7)d, SD-Ag组为(10．8±3．4)d,用药后7 d创面愈合率分别为(77．9±20．5)％及(67．3±22．6)％;深Ⅱ度创面:AgNO3组完全愈合时间为(21．5±4．8)d,SD-Ag组为(23．3±6,4)d,用药后20 d创面愈合率分别为(86．6±15．9)％及(78．5±17．7)％。同等深度烧伤创面上述各项数据两组间比较,差异均有统计学意义(P<0．01)。同等深度烧伤创面AgNO3组与SD-Ag组比较,具有同样明显的杀菌作用,但前者对创面的刺激性更小。结论AgNO3软膏是一种可用于浅Ⅱ、深Ⅱ度烧伤创面的有效、安全的外用药。     

重组人表皮生长因子与复合溶菌酶联合治疗儿童烧伤创面的效果研究

目的:观察重组人表皮生长因子与复合溶菌酶联合治疗儿童烧伤创面的临床效果,为临床治疗儿童烧伤提供一种新的治疗方法。方法:将80例儿童烧伤患者采用自身对照选择相同深度的两个创面随机分为治疗组与对照组进行研究治疗。治疗组给予重组人表皮生长因子与复合溶菌酶联合治疗;对照组给予硝酸银软膏治疗。临床观察创面愈合时间、创面炎症反应发生情况、创面细菌培养情况、过敏反应、创面愈合3个月后期随访有无色素沉着或脱失、瘢痕增生的情况。结果:治疗组比对照组创面愈合时间明显缩短,减少创面炎症反应及感染机会,治疗组明显优于对照组(P<0.05);患者未出现过敏反应和其它不良反应,后期随访瘢痕增生少。结论:重组人表皮生长因子与复合溶菌酶联合治疗儿童烧伤创面,明显缩短创面愈合时间,减轻创面炎症反应,疗效可靠。在今后儿童烧伤创面治疗中具有广阔的临床发展前景,适用于基层医院使用。     

创面用变革对深Ⅱ°烧伤创面愈合时间的影响

目的通过对深Ⅱ°烧伤创面愈合时间的分阶段对比分析,了解创面愈合观念及创面用药变革对创面愈合速度的影响。方法1982年1月～1999年12月对1563例小面积深Ⅱ°烧伤患者(总面积≤10%),按创面补锌及生长因子和胶原酶应用等治疗措施采用时间不同,分为时间阶段,对比观察创面愈合速度变化。结果1982年1月～1990年12月,未使用特殊创面外用药物,创面愈合时间为(23.8±3.5)天;1991年～1996年,采用银锌霜创面补锌,创面愈合时间为(20.6±3.2)天;1997年～1999年,将脱痂药物(胶原酶)及生长因子与银锌霜联合使用,使创面愈合时间缩短为(16.2±2.8)天。结论创面愈合观念及创面用药变革促进了深Ⅱ°创面愈合。     

Enhanced healing of full-thickness burn wounds using di-rhamnolipid

The aim of this study was to investigate the properties of di-rhamnolipid [alpha-L-rhamnopyranosyl-(1-2)-alpha-L-rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoic acid, also referred to as di-rhamnolipid BAC-3] relating to the process of cutaneous wound healing. Di-rhamnolipid was prepared in a eucerin ointment and applied topically on full-thickness burn wounds in normal Sprague-Dawley rats covering 5% of the total body surface area. The rate of wound closure was measured over the period of 45 days. The collagen content was evaluated microscopically, by performing densitometric analysis on Verhoeff's stained histopathological slides of wound biopsies taken at the end of 45th day of di-rhamnolipid treatment. Di-rhamnolipid toxicity was assessed with the subcutaneous multi-dose study in Swiss-Webster mice. The treatment of full-thickness-burn wounds with topical 0.1% di-rhamnolipid accelerated the closure of wounds on day 21 of the treatment by 32% compared to the control (p < 0.05). On day 35, the wounds closed in all animals-treated with 0.1% di-rhamnolipid ointment while some rats in the control group had open wounds on days 35 and even 45. Histologic comparisons have shown that di-rhamnolipid significantly decreased collagen content in burn wounds (47.5%, p < 0.05) as compared to the vehicle-treated (control) wounds. Di-rhamnolipid was well-tolerated. The results of this study raise the possibility of potential efficacy of di-rhamnolipid in accelerating normal wound healing and perhaps in overcoming defects associated with healing failure in chronic wounds.     

The effect of henna and linseed herbal ointment blend on wound healing in rats with second-degree burns

The treatment of skin burns is one of the most important challenge in medical science. The aim of this study is evaluation of the efficacy of Artaderm herbal ointment containing the Henna (Lawsonia inermis) extract, Linseed (Linum usitatissimum) oil, and Honey Wax on wound healing in the rat with second-degree burn wounds. The Artaderm ointment had an effective role in controlling burn wound infections due to its antimicrobial and anti-inflammatory properties. In this study, 64 male Wistar rats were randomly divided into 8 groups (n = 8). Four groups received Artaderm, 1% Silver Sulfadiazine (SSD 1%), Cod Liver Oil and Fundermol (Alpha) ointments which used in common practices for burn injuries. Another three groups received Henna, Linseed, and Honey Wax alone and a control group that just underwent a second-degree burn injury without any treatments. A second-degree burn was formed on the back of each rat and dressed daily with one of the agents. Burn wounds were macroscopically and microscopically evaluated on the 7th, 14th, and 21st day after burn induction. Rats treated with the Artaderm ointment had significantly faster wound contraction as well as shorter healing time than the rest groups. No scar was observed in rats treated with the Artaderm ointment on the 21st day, while this level of improvement was not observed in other groups at the same time. More than 90% of wounds were healed after on the 14th day in rats treated with Artaderm (94.10 ± 0.18) and Alpha (92.05 ± 0.23) ointments. According to these findings, it can be concluded that Artaderm herbal ointment can be used as a proper alternative for healing of wounds in second-degree burns.     

Moist exposed therapy of partial-thickness burn wounds. A multi-center study

Summary In laser-induced partial-thickness burns of pig skin, moist exposed burn ointment (MEBO) produces a moist environment, allows drainage of exudates, reduces eschar formation, and accelerates debridement and wound healing. A prospective multi-center study was conducted to evaluate the effect of MEBO on the healing of partial-thickness burn wounds. We included 52 patients with 100 burn sites ranging from 0.5% to 15% total body surface area in the study. Treatment efficacy was assessed on physical examination of the wound, the course of time of trans-epidermal water loss (TEWL) and moisture values, bacterial wound colonization and the degree of pain experienced by patients during and between dressing changes. Using the Visual Analogue Thermometer device (VAT) a progressive decrease of pain was found throughout the treatment which was statistically significant at 6, 9 and 12 post-burn days. TEWL, as an indicator of re-epithelialization, demonstrated a decreasing trend on day 3, and the reduction became significant from the 6th post-burn day. Moisture was significantly decreased during the first 5 post-burn days. As re-epithelialization progressed there was a net decrease in moisture paralleling TEWL. After 1 week of MEBO treatment, bacterial wound colonization decreased to 10% in the immediate group and to 61% in the late group of application. By the second week, colonization dropped to 5% and 23% respectively. Topical ointment application contributed to the debridement of the wound bed facilitating rapid epithelialization within 2–6 days, depending on the burn depth. MEBO is an ointment that can effectively produce a moist and wet environment for optimal healing of partial-thickness burns.     

Antibiotic ointment versus a silver-based dressing for children with extremity burns: A randomized controlled study

IntroductionAntibiotic or silver-based dressings are widely used in burn wound care. Our standard method of dressing pediatric extremity burn wounds consists of an antibiotic ointment or nystatin ointment-impregnated nonadherent gauze (primary layer), followed by rolled gauze, soft cast pad, plaster and soft casting tape (3M? Scotchcast?, St. Paul, MN). The aim of this study was to compare our standard ointment-based primary layer versus Mepitel Ag^® (Mölnlycke Health Care, Gothenburg, Sweden) in the management of pediatric upper and lower extremity burn wounds.MethodsChildren with a new burn injury to the upper or lower extremities, who presented to the burn clinic were eligible. Eligible children were enrolled and randomized, stratified by burn thickness, to be dressed in an ointment-based dressing or Mepitel Ag®. Study personnel and participants were not blinded to the dressing assignment after randomization. Dressings were changed approximately once or twice per week, until the burn wound was healed or skin-grafted. The primary outcome was time to wound healing and p-value < 0.05 was considered significant.ResultsNinety-six children with 113 upper or lower extremity burns were included in the analysis. Mepitel Ag® (hazard ratio [HR] 0.57 (95% Confidence Interval (CI) 0.40–0.82); p = 0.002) significantly reduced the rate of wound healing, adjusting for burn thickness and fungal wound infection. The incidence of fungal wound infections and skin grafting was similar between the two groups. Children randomized to standard ointment dressings were significantly less likely to require four or more burn clinic visits than those in the Mepitel Ag^® (4% versus 27%; p = 0.004).ConclusionOur study shows that our standard ointment-based dressing significantly increases the rate of wound healing compared to Mepitel Ag^® for pediatric extremity burn injuries.Level of evidenceTreatment study; Level 1.     

A recombinant human collagen hydrogel for the treatment of partial-thickness burns: A prospective,self-controlled clinical study

IntroductionAllogeneic and xenogeneic skin are recognized as the best coverings for skin burn wounds, but currently face a supply shortage. To solve this problem, our research group developed a standardized manufactured hydrogel dressing based on a new type of highly bioactive recombinant human collagen.Study designProspective self-controlled trial.ObjectiveTo evaluate the efficacy and safety of recombinant human collagen hydrogel in the treatment of partial burn wounds to the skin compared to those of xenogeneic skin.MethodsThis study included twenty-one patients admitted to Shanghai Changhai Hospital within 48 h after receiving partial-thickness skin burns. The wounds were symmetrically separated along the axis and treated with recombinant human collagen hydrogel (RHCH) or a human-CTLA4-Ig gene-transferred pig skin xenotransplant. The condition of the wound surfaces was recorded on days 0 (of enrollment), 5, 10, 15, and 20, and bacterial drug sensitivity testing, hematuria examination, and electrocardiographic tests were conducted on days 0, 10, 20, or on the day of wound healing.ResultsThere were no statistically significant differences in wound healing time between the two groups. The median number of days to healing was 11.00 ± 0.56 for xenogeneic skin vs. 11.00 ± 1.72 for RHCH.ConclusionDuring the observation period, the therapeutic effect of the RHCH developed by our group on partial-thickness burn wounds was not significantly different from that of gene-transferred xenogeneic skin. Thus, our designed RHCH shows potential for clinical use to treat burn wounds on the skin.     

组织工程皮肤修复烧伤后残余创面的临床观察

目的：观察创面直径为5-7cm的烧伤后残余创面应用组织工程皮肤治疗的效果。方法：笔者单位2008年5月-2012年7月的12例烧伤后残余创面患者,采用同体对照的研究方法,每例患者选择2处直径为5-7cm的残余创面,随机分为组织工程皮肤治疗组和对照组。两组创面细菌培养阳性菌株均相同。两组受试创面面积比较差异无统计学意义（P〉0．05）,具有可比性。患者均进行浸浴治疗后,受试创面给予外用莫匹罗星软膏,每日换药1次。在局部感染控制后组织工程皮肤治疗组创面清创后移植组织工程皮肤,对照组继续换药治疗,同时予以全身抗感染治疗。结果：本组12例患者组织工程皮肤治疗组创面均在移植组织工程皮肤后1-2周愈合,均未进行自体皮移植,愈合质量良好;对照组创面在相同时间内均未愈合,最终均给予自体皮移植而愈合。结论：经充分创面准备后移植组织工程皮肤可用于修复直径较大的烧伤后残余创面,以替代传统的自体皮移植。     

Effect of piracetam and nimodipine on full‐thickness skin burns in rabbits

The potential of several drugs for full‐thickness skin burns has been investigated, but the treatment of such burns remains a challenge in plastic surgery. The present study was designed to determine the effect of systemic and topical administration of piracetam and nimodipine on full‐thickness skin burn wound healing. A total of 36 New Zealand male rabbits were divided into six groups. Full‐thickness skin burns were produced in all the groups, except the control group. Piracetam was administered systemically (piracetam‐IV) and topically (piracetam‐C) for 14 days, and nimodipine was administered systemically (nimodipine‐IV) and topically (nimodipine‐C) over the burn wounds for 14 days. The sham group underwent burn injury but was not administered any drug. After 21 days, gross examination and histopathological analysis were performed and the results were compared statistically. Nimodipine‐C and nimodipine‐IV had no effect on burn wound healing. However, both piracetam‐IV and piracetam‐C significantly enhanced the healing of the full‐thickness skin burn wounds, although the latter was more effective, useful and practical in burn wound healing. The histopathological features of the wounds in the piracetam‐C group were closer to those of the control group than those of the other groups. Piracetam‐C rather than piracetam‐IV may promote full‐thickness burn wound healing in rabbits.     

Wound healing potential of Pterocarpus santalinus linn: a pharmacological evaluation

The need for new therapeutics for wound healing has encouraged the drive to examine the nature and value of plant products. Ayurveda, the Indian traditional system of medicine, mentions the values of medicinal plants for wound healing. One of these is Pterocarpus santalinus. This article describes a pharmacological study to evaluate its toxicity as well as wound-healing potential in animal studies. Powder made from the wood of the P. santalinus tree was used to make up an ointment in a petroleum jelly base. No toxic effects were observed in 72 hours. Studies were done on punch and burn wound models on normal and diabetic rats using the test ointment, untreated and vehicle controls, and standard therapy. Physical and biochemical measurements were made. The test ointment-treated wounds healed significantly faster. On healing, collagenesis and biochemical measurements yielded supportive data. These studies permit the conclusion that the P. santalinus ointment is safe and effective in treating acute wounds in animal models.     

硝普钠和磺胺嘧啶银联合应用对大鼠深Ⅱ度烧伤创面愈合的影响

目的：研究硝普钠、磺胺嘧啶银及二者合用对深Ⅱ度烧伤皮肤创面愈合的影响。方法：100只WiStar大鼠背部深Ⅱ度烧伤创面,随机分成0．9％氯化钠注射液组、1％磺胺嘧啶银霜组、lmmol／L硝普钠组和1％磺胺嘧啶银霜＋lmmol／L硝普钠组。每组25只大鼠。动态观察烧伤后不同时间点创面细胞增殖周期、羟脯氨酸含量及创面组织愈合情况,计算创面愈合率。结果：伤后随时间推移磺胺嘧啶银霜＋硝普钠组创面愈合率高于其他三组;伤后第10天,磺胺嘧啶银霜＋硝普钠组创面羟脯氨酸含量、细胞S期百分比达到峰值,明显高于0．9％氯化钠注射液（P〈O．01）,磺胺嘧啶银霜组、硝普钠组之间比较无显著差异（P〉0．05）。结论：磺胺嘧啶银霜和硝普钠合用可有效促进大鼠深Ⅱ度烧伤创面愈合。     

Topically applied rhGM-CSF for the wound healing: a systematic review

The process of wound healing involves a complex interplay of cells, mediators, growth factors and cytokines. GM-CSF has been shown to be involved in a number of processes essential in this event. Topically applied rhGM-CSF has been reported to successfully treat wounds with diverse etiology, including burns, chronic venous leg ulcers, pressure ulcers, and leprosy ulcers, both in animal experiments and clinical studies. To evaluate the effect of the rhGM-CSF on wound healing, 8 RCT studies and 23 clinical studies and case reports are collected for analysis of the evidence. The overall effects of rhGM-CSF on the healing of wound are diverse. Topically applied rhGM-CSF is beneficial for deep partial-thickness burn wounds, chronic leg ulcers, and leprosy ulcers. rhGM-CSF may have a positive effect on other type of chronic ulcers such as pressure ulcers and cancer related ulcers, but the evidence is not sufficient for generalised use at present. rhGM-CSF is suggested have no accelerating effect on the healing of healthy wounds or surgical incisions.     

湿润烧伤膏治疗烧伤患者的临床疗效及安全性

目的 探讨湿润烧伤膏用于治疗烧伤患者的疗效及安全性。方法 选择河北省沧州中西医结合医 院东院区2020年1月-2021年12月收治的40例烧伤患者，根据治疗方法的不同将其分为观察组和对照组，各 20例。对照组采用磺胺嘧啶银乳膏治疗，观察组采用湿润烧伤膏治疗，比较两组临床疗效、恢复时间、疼 痛程度以及瘢痕情况。结果 观察组治疗总有效率为95.00%，高于对照组的70.00%（P＜0.05）；观察组创 面愈合时间、肉芽生长时间均短于对照组（P＜0.05）；两组治疗后VAS疼痛评分均降低，且观察组低于对 照组（P＜0.05）；观察组瘢痕发生率及瘢痕严重程度低于对照组（P＜0.05）。结论 为烧伤患者提供湿润 烧伤膏进行治疗，可提升临床疗效，缓解疼痛程度，缩短患者创面愈合时间和肉芽生长时间，降低瘢痕发 生率，其疗效及安全性均得到保障。     

The use of transposed rectus femoris muscle in the treatment of infected abdominal wounds

Summary A recent publication, where three experienced workers in the field of managing post-operative contaminated open wounds, especially of the abdominal wall, underscores the considerable number of different methods that are in vogue. Infected abdominal wounds are usually treated by debridement, the administration of appropriate antibiotics and wound closure on a delayed basis. In the presence of a surgical implant, the latter is often partially or completely removed depending on the circumstances that led to its insertion. While healing often results, there remain a hard core of recalcitrant cases where multiple operations are necessary to heal the wound. Over 30 years ago a method was introduced to treat a variety of non-healing and infected wounds, namely the use of transposed muscles. Experience shows that this approach is either unknown or rejected by physicians treating patients with recalcitrant wounds and, at times, major ablations are performed. Introduced originally by a general surgeon, the procedure is better known by those engaged in plastic surgery. At our wound center, patients who have been unsuccessfully treated by multiple operations are regularly seen, which indicates that physicians need to be reminded of this proven, but perhaps forgotten, method of management. For this reason an illustrative case report is presented of a patient whose abdominal wall hernia was treated and which resulted in an infected non-healing wound that was successfully managed using a transposed rectus femoris muscle.     

Enzymatic wound debridement

BACKGROUND: Clinical experience and existing research strongly support debridement as a necessary component of wound bed preparation when slough or eschar is present. Multiple techniques are available, but the indications for each technique and their efficacy are not clearly established. There is little evidence to guide the clinician in the selection of a safe, effective debridement method for the patient with a chronic wound. OBJECTIVES: We sought to identify evidence related to the efficacy of enzymatic debriding agents collagenase and papain-urea in the removal of necrotic tissue from the wound bed and its impact on wound healing. SEARCH STRATEGY: A systematic review of electronic databases was undertaken using key words: (1) debridement, (2) enzymatic debridement, (3) collagenases, (4) papain, (5) urea, and (6) papain-urea. All prospective and retrospective studies that compared enzymatic debridement using collagenase or papain-urea (with and without chlorophyllin) on pressure ulcers, leg ulcers, or burn wounds were included in the review. All studies that met inclusion criteria and were published between January 1960 and February 2008 were included. RESULTS: Collagenase ointment is more effective than placebo (inactivated ointment or petrolatum ointment) for debridement of necrotic tissue from pressure ulcers, leg ulcers, and partial-thickness burn wounds. Limited evidence suggests that a papain-urea-based ointment removes necrotic material from pressure ulcers more rapidly than collagenase ointment, but progress toward wound healing appears to be equivocal. Limited evidence suggests that treatment of partial-thickness burn wounds in children with collagenase ointment may require an equivocal time to treatment with surgical excision and that combination treatment may reduce the need for surgical excision. Insufficient evidence was found to determine whether collagenase ointment removes necrotic tissue from leg ulcers more or less rapidly than autolytic debridement enhanced by a polyacrylate dressing. IMPLICATIONS FOR PRACTICE: Enzymatic debriding agents are an effective alternative for removing necrotic material from pressure ulcers, leg ulcers, and partial-thickness wounds. They may be used to debride both adherent slough and eschar. Enzymatic agents may be used as the primary technique for debridement in certain cases, especially when alternative methods such as surgical or conservative sharp wound debridement (CSWD) are not feasible owing to bleeding disorders or other considerations. Many clinicians will select enzymes when CSWD is not an option. Clinical experience strongly suggests that combined therapy, such as initial surgical debridement followed by serial debridement using an enzymatic agent or enzymatic debridement along with serial CSWD, is effective for many patients with chronic, indolent, or nonhealing wounds.     

自体表皮细胞-纤维蛋白膜创面移植治疗大鼠烧伤

目的：观察自体表皮细胞-纤维蛋白膜移植到大鼠烧伤创面治疗皮肤缺损的效果。方法：健康Wistar大鼠20只,随机分成烧伤皮肤缺损造模组和自体表皮细胞-纤维蛋白膜移植治疗组,治疗后计算表皮细胞在纤维蛋白膜上最佳接种密度,观察移植后的各组创面愈合情况、创面伤口的收缩比例等。结果：在纤维蛋白膜上接种表皮细胞的最佳密度为5×10^4／cm2,烧伤皮肤缺损造模组创面完全愈合时间平均22．3d,自体表皮细胞-纤维蛋白膜移植治疗组为18．1d,造模组创面收缩率为（70±5）％,移植组为（20±5）％（均P〈0．05）。结论：自体表皮细胞-纤维蛋白膜可用于覆盖大面积烧伤造成的皮肤缺损,预防创面伤口瘢痕化的形成,减轻创面收缩率,加速皮肤缺损创面的愈合速度。     

Moist exposed burn therapy: evaluation of the wound healing process. An experimental model to assess the efficacy of local agents on wound repair in partial- and full-thickness wounds

The porcine model was used to investigate the wound healing process. 116 partial and full-thickness wounds were induced on the back of the animals using the CO₂ Three local dressing agents were tested: Povidone Iodine, Silver Sulphadiazine and MEBO ointments. The following parameters were evaluated: physical examination, photography, pH, transepidermal water loss and moisture of the wound, planimetry and histological assessment of injury. The measurement of different parameters revealed that partial-thickness burn wounds were better assessed using Transepidermal Water Loss (TEWL), while full-thickness ones are better assessed using planimetry, measuring the surface of the wound. MEBO significantly accelerates the wound healing process of partial- (inflicted by CO₂ Laser) and full-thickness excised wounds when compared to other local agents applied on wounds similar in size, extent and cause and the control group.     

Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns

The goal of this study was to evaluate the efficacy of Alpha ointment in the treatment of burn wounds and compare its results with silver sulfadiazine (SS). Similar burn ulcers were produced on anterior surface of thigh of 60 rats. The wounds were infected with Pseudomonas aeruginosa and dressing and debridement was performed daily. The first group of rats received topical SS, the second group received Alpha ointment and the third (control group) received no medication. Wound healing, contraction, culture, and scar formation were evaluated at the end of the second and 10th week. Alpha ointment was equally effective as SS, considering wound healing and contraction. Wound infection was significantly less common in Alpha ointment group compared to the other two groups (p<0.05). Alpha ointment is a less expensive drug with an acceptable result compared to SS. Therefore, we recommend it as an alternative to SS, especially in patients with low economical backgrounds or in those who show adverse reactions to SS.